My data points for potential stock price rising is DNDN. They had a much lower revenue potential and with good data and fda approval they went up to a $8B market cap at its peak. MNKD has a much greater potential and I am expecting at least a $5B market cap on great data. That would take us to about $16 on data news. Partner before then end of the year and we gap up to $20 - $25. FDA approval and we are at $30 - $40. At $30 this is a $9B company. Like I said DNDN went to $8B with at the time they were saying they could do $2B in revenues. MNKD can do $20B in revenue if they have what they say they have.

We shall see.